<--- Back to Details
First PageDocument Content
Microbiology / Streptococcus pneumoniae / Pneumococcal conjugate vaccine / Antibiotic resistance / Acute exacerbations of chronic bronchitis / Macrolide / Community-acquired pneumonia / Haemophilus influenzae / Clindamycin / Bacteria / Pneumonia / Medicine
Date: 2007-01-16 14:32:13
Microbiology
Streptococcus pneumoniae
Pneumococcal conjugate vaccine
Antibiotic resistance
Acute exacerbations of chronic bronchitis
Macrolide
Community-acquired pneumonia
Haemophilus influenzae
Clindamycin
Bacteria
Pneumonia
Medicine

Microsoft PowerPoint - 02_LowFDA_ver1-0.ppt

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 431,19 KB

Share Document on Facebook

Similar Documents

Vitamin D as an adjunct for acute community-acquired pneumonia among infants and children: systematic review and meta-analysis

DocID: 1tt5b - View Document

Medicine / Infectious diseases / Bacteria / Clinical medicine / Pneumonia / Mollicutes / Respiratory diseases / Pathogenic bacteria / Mycoplasma / Respiratory tract infection / Community-acquired pneumonia / Bacterial pneumonia

Rise in hospital admission due to Mycoplasma pneumoniae infection in Hong Kong

DocID: 1riuz - View Document

6.5 COMMUNITY ACQUIRED PNEUMONIA IN CHILDREN AND YOUNG PEOPLE Acute pneumonia is infection and inflammation in the small air sacs and tissues of the lung, rather than infection/inflammation in the breathing tubes (bronch

DocID: 1fkdk - View Document

Clinical Microbiology and Infection, Volume 10, Supplement 3, Community-acquired infections: focus on unusual epidemics and update on S. pneumonia P430 Community-acquired pneumonia caused by ‘atypical’ patho

DocID: 1f1ps - View Document

6.4 COMMUNITY ACQUIRED PNEUMONIA IN ADULTS Community acquired pneumonia refers to pneumonia acquired outside of hospitals. It is estimated that 14,000 people are treated

DocID: 1cXuC - View Document